Evaluating Diabetes Drug Targets for Vascular Dementia Prevention Using Drug Target Mendelian Randomisation
Amy E. Packer, Lauren Austin, Dylan M. Williams, Victoria Taylor‐Bateman, Emma Louise Anderson
This study uses Mendelian randomisation to assess if diabetes drug targets affect vascular dementia risk, finding no strong evidence but a suggestive protective effect for DPP4 inhibition.
medRxiv · Sep 29, 2026 · PreprintGenetic & Genomic Medicine